rs369215974
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_001164508.2(NEB):c.6175G>A(p.Ala2059Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000109 in 1,603,152 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001164508.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.6175G>A | p.Ala2059Thr | missense_variant | Exon 48 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
NEB | ENST00000427231.7 | c.6175G>A | p.Ala2059Thr | missense_variant | Exon 48 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
NEB | ENST00000409198.5 | c.6175G>A | p.Ala2059Thr | missense_variant | Exon 48 of 150 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000903 AC: 22AN: 243512Hom.: 1 AF XY: 0.0000834 AC XY: 11AN XY: 131908
GnomAD4 exome AF: 0.000108 AC: 156AN: 1450850Hom.: 1 Cov.: 30 AF XY: 0.0000914 AC XY: 66AN XY: 721808
GnomAD4 genome AF: 0.000125 AC: 19AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74462
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
- -
NEB-related disorder Uncertain:1
The NEB c.6175G>A variant is predicted to result in the amino acid substitution p.Ala2059Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.017% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
See cases Benign:1
ACMG classification criteria: PM2, BP1, BP4 -
Nemaline myopathy 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at